Virax Biolabs Group Limited Ordinary Shares (VRAX) — Financial Flexibility Index
Virax Biolabs Group Limited Ordinary Shares (VRAX) has a Financial Flexibility Index of -4.34x as of September 2025. Free cash flow of $-2.78 Million (operating CF $-2.92 Million minus capex $141.50K) represents -4% of total liabilities ($641.52K). Also explore VRAX year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Virax Biolabs Group Limited Ordinary Shares Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Virax Biolabs Group Limited Ordinary Shares across 6 annual periods. Check Virax Biolabs Group Limited Ordinary Sha liquidity resilience to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Virax Biolabs Group Limited Ordinary Shares (2020–2025)
Year-by-year free cash flow to debt coverage for Virax Biolabs Group Limited Ordinary Shares. For the full company profile including market capitalisation, see market value of Virax Biolabs Group Limited Ordinary Sha.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.10x | $-3.96 Million | $-4.56 Million | $964.75K | ▲ +72.1% |
| 2024 | -14.72x | $-5.08 Million | $-6.25 Million | $345.19K | ▼ -234.3% |
| 2023 | -4.40x | $-4.00 Million | $-4.18 Million | $908.40K | ▼ -578.0% |
| 2022 | -0.65x | $-809.07K | $-809.07K | $1.25 Million | ▲ +4.1% |
| 2021 | -0.68x | $-590.19K | $-590.19K | $871.43K | ▼ -12.6% |
| 2020 | -0.60x | $-744.61K | $-744.61K | $1.24 Million | — |